The tumor suppressor LRP1B, known to correlate with high tumor mutational burden and increased neoantigen load, was frequently co-mutated with KMT2C and EP300, particularly in UTUC, where both LRP1B and chromatin remodeling genes are recurrently altered (34, 35). Here, LRP1B is linked to neoplasm.